< Back to Results
Primary Contact Name
Ofelia Kiedpool
Primary Contact Email Address
okiedpool@coh.org
Primary Contact Phone Number
6262183497
Program Name
Hematopoietic Cell Transplantation and Cellular Therapy Fellowship
Address
1500 E Duarte Road
Duarte, CA, 91010
Website
https://www.cityofhope.org/academics/graduate-medical-education/clinical-residency-and-fellowships/hct-fellowship
Program Director/Fellowship Director
Karamjeet Sandhu
Program Director/Fellowship Director Email
ksandhu@coh.org
Is the primary focus of your program on Blood and Marrow Transplantation (BMT) or Cellular Therapies?
BTH
How long is the Fellowship program at your institution?
One Year
How long is the BMT Fellowship program at your institution?
Not Provided
Option to extend training or research if funding is available?
Yes
Is the primary focus of your program on adult or pediatric populations?
Adult
How long before the Fellowship start date should applicants apply?
7-12 Months
When does your Fellowship application period begin?
September
When does your Fellowship application period end?
March
How many training spaces?
Three
If you selected other, how many training spaces are there?
Not Provided
When does your program typically start?
July
If flexible, please describe
Not Provided
If you selected yes, please specify the type of visa
Not Provided
What are the requirements for fellows applying to your program?
Completion of residency training (Board Certified) or equivalent abroad, Completion of Hematology and/or Oncology Fellowship or equivalent (Board Eligible), ECFMG certification if IMG applicant, Eligibility to obtain a State Medical License
If you selected other, please explain
Not Provided
Are there any unique training opportunities in your fellowship program? (For example: rotation with CTRM, H&I Lab, exposure to CAR T Therapy, etc.)
City of Hope performs the highest number of allogeneic HCT in the U.S. and is also one of the highest volume IEC centers. This fellowship provides extensive clinical training in all aspects of HCT including patient selection, HLA typing, assessment and management of toxicities, donor and graft selection. Furthermore, fellows will also be trained in IEC therapy which includes but is not limited to CAR-T therapy and fellows will gain competency in patient assessment, product selection, and management of complications associated with various IEC products across a variety of indications including experimental products in both hematologic and solid malignancies.
,
, In addition to an in-depth clinical experience at a high-volume center, fellows will also be provided protected time to perform clinical and translational research. These efforts are led by world-renowned clinical, translational, and basic science faculty. Furthermore, ample opportunity exists for multidisciplinary research with faculty in diverse areas such as immuno-oncology, stem cell biology, gene therapy, aging, precision medicine, and infectious diseases.
Continuity Clinic with trainee as primary physician with supervision?
Yes
Approximate volume of cases at your center for the following
Autologous Transplant
Not Provided
Allogeneic Transplant
Not Provided
Approximate Structure (In weeks)
Inpatient
Not Provided
Outpatient/Consults
Not Provided
Other (specify)
Not Provided
Sample Schedule Upload
Not Provided
Educational Stipend/Conference funding available:
Yes - Specify
Specify the Educational Stipend/Conference funding available
Not Provided
If you were interested in the standard time frame, what part of the process would you be interested in standardizing?
Not Provided
< Back to Results